financetom
Business
financetom
/
Business
/
Infosys acquires Irish startup Eishtec, says report
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Infosys acquires Irish startup Eishtec, says report
Oct 9, 2019 5:13 AM

IT major Infosys has acquired Irish customer contact centre operator Eishtec for an undisclosed amount, reported The Irish Times.

Eishtec, the report said, informed its staff about the development on Monday and told them they would be transferred to the Bengaluru-based IT services firm. The Irish firm that has approximately 1400 employees informed its staff in a statement that the merger would provide an opportunity for growth.

“The entire Eishtec team is excited about the new chapter in the company’s journey. The company’s owners have been working with a leading business process outsourcing company over the last few months and have made the strategic decision to transition the business to be part of Infosys BPM,” chief executive Heather Reynolds was quoted as saying in the report.

Established back in 2011, the Irish firm provides services to the telecoms, social media, healthcare, edtech and fintech sectors. As per the deal, the report said, the current management team at Eishtec will remain intact while some of the employees may be transferred.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Fortrea Holdings's Q4 Adjusted Earnings Increase, Revenue Declines; 2025 Revenue Outlook Issued
Fortrea Holdings's Q4 Adjusted Earnings Increase, Revenue Declines; 2025 Revenue Outlook Issued
Mar 3, 2025
07:02 AM EST, 03/03/2025 (MT Newswires) -- Fortrea Holdings ( FTRE ) reported Q4 adjusted earnings Monday of $0.18 per diluted share, up from $0.14 a year earlier. Analysts polled by FactSet expected $0.37. Revenue for the quarter ended Dec. 31 was $697 million, compared with $709.7 million a year earlier. Analysts polled by FactSet expected $703.3 million. The company...
ADT Secondary Common Stock Offering Launches; Shares Down Pre-Bell
ADT Secondary Common Stock Offering Launches; Shares Down Pre-Bell
Mar 3, 2025
07:02 AM EST, 03/03/2025 (MT Newswires) -- ADT (ADT) said Monday that a secondary public offering of 70 million common shares of the company held by certain entities managed by Apollo Global Management ( APO ) affiliates launched. Underwriters will have a 30-day overallotment option to purchase up to 10.5 million additional shares. As part of the offering, the company...
Guardian Pharmacy Services Preliminary Q4 Net Income Declines, Revenue Increases; 2025 Guidance Issued
Guardian Pharmacy Services Preliminary Q4 Net Income Declines, Revenue Increases; 2025 Guidance Issued
Mar 3, 2025
06:59 AM EST, 03/03/2025 (MT Newswires) -- Guardian Pharmacy Services ( GRDN ) reported preliminary Q4 income Monday of $10.1 million to $11.1 million, down by $3.5 million to $4.5 million from a year earlier. Three analysts polled by FactSet expect $10.5 million. Revenue for the quarter ended Dec. 31 is expected to be $338.6 million, up 20.5% from a...
Astrazeneca-Amgen Asthma Treatment Reduces Nasal Polyps, Surgery Rates in Phase III Trial
Astrazeneca-Amgen Asthma Treatment Reduces Nasal Polyps, Surgery Rates in Phase III Trial
Mar 3, 2025
06:59 AM EST, 03/03/2025 (MT Newswires) -- Astrazeneca ( AZN ) said Saturday the full results from the Phase III trial showed Tezspire or tezepelumab, an asthma treatment jointly developed with Amgen ( AMGN ) , led to significant reductions in nasal polyp severity, surgery requirements, and systemic corticosteroid use for patients with chronic rhinosinusitis with nasal polyps, compared with...
Copyright 2023-2026 - www.financetom.com All Rights Reserved